The phytocompound chrysotobibenzyl, isolated from the stems of the orchid species Dendrobium pulchellum (family Orchidaceae), shows an inhibitory effect on lung cancer cell migration by suppressing caveolin-1 (CAV-1) activity, integrins, and the epithelial-to-mesenchymal transition (EMT), according to the study by Petpiroon et al. Other compounds isolated from species of the genus Dendrobium also have anti-metastatic effects in the treatment of lung cancer, such as giganthol (D. draconis), chrysotoxins, crepidatin, and moscatilin (D. pulchellum). The gene discussed is CAV1; the disease is lung carcinoma.